Pemphigus vulgaris: A 11-year review

Bratislava Medical Journal

Volumn 110, Issue 8, 2009, Pages 500-503

  Chmurova, N ^a   Svecova, D ^a  

^a Bratislava   (Slovakia)

Author keywords

Corticosteroids; Pemphigus vulgaris; Side effects; Therapy; Triggering factors

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; FEMALE; HUMAN; MALE; MIDDLE AGED; PATHOLOGY; PEMPHIGUS;

ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; PEMPHIGUS; YOUNG ADULT;

EID: 68649114548     PISSN: 00069248     EISSN: 13360345     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Vlckova-Laskoska MT, Laskoski DS, Kamberova S, Caca-Biljanovska N, Volckova N. Epidemiology of pemphigus in Macedonia: A 15-year retrospective study (1990-2004). Int J Dermatol 2007; 46: 253-258.
2. Cetkovská P. Autoimunitní bulózní dermatózy. Čes.-slov. Derm 2004; 81: 188-196.
3. Fassmann A, Dvořáková N, Izakovičová Hollá L, Vanék J, Wotke J. Manifestation of pemphigus vulgaris in the orofacial region. Scripta Medica (Brno) 2003; 76: 55-62.
4. Gorsky M, Raviv M, Raviv E. Pemphigus vulgaris in adolescence. A case presentation and review of literature. Oral Surg Oral Med Oral Pathol 1994; 77: 620-622.
5. Tur E, Brenner S. Contributing exogenous factors in pemphigus. Int J Dermatol 1997; 36: 888-893.
6. Glorio R, Rodriguez Costa G, Haas R, Gruber M, Fainboim L, Woscoff A. HLA haplotypes and class II molecular alleles in Argentinian patients with pemphigus vulgaris. J Cutan Med Surg 2002; 6: 422-426.
7. Michailidou EZ, Belazi MA, Markopoulos AK, Tsatsos MI, Mourellou O, Antoniades DZ. Epidemiologic survey of pemphigus vulgaris with oral manifestations in northern Greece: Retrospective study of 129 patients. Int J Dermatol 2007; 46: 356-361.
8. Ljubojevic S, Lipozenčic J, Brenner S, Budimčic D. Pemphigus vulgaris: a review of treatment over a 19-year period. J Eur Acad Der matol Venereol 2002; 16: 599-603.
9. Lagha NB, Poulesquen V, Roujeau JC, Alantar A, Maman L. Pemphigus Vulgaris: A Case-Based Update. J Can Dent Assoc 2005; 71: 667-672.
10. Kavusi S, Daneshpazhooh M, Farahani F, Abedini R, Lajevardi V, Chams-Davatchi C. Outcome of pemphigus vulgaris. J Eur Acad Dermatol Venereol 2008; 22: 580-584.
11. Uzun S, Durdu M, Akman A et al. Pemphigus in the Mediterranean region of Turkey: a study of 148 cases. Int J Dermatol 2006; 45: 523-528.
12. Kyriakis KP, Tosca AD. Epidemiologic observations on the natural course of pemphigus vulgaris. Int J Dermatol 1998; 37: 215-219.
13. Nurul Amin M, Nurul Islam AZM. Clinical, histologic and immunologic features of pemphigus in Bangladesh. Int J Dermatol 2006; 45: 1317-1318.
14. Mahé A, Flageul B, Cissé I, Kéita S, Bobin P. Pemphigus in Mali: a study of 30 cases. Brit J Dermatol 1996; 134: 114-119.
15. Camacho-Alonso F, López-Jornet P, Bermejo-Fenoll A. Pemphigus vulgaris. A presentation of 14 cases and review of the literature. Med Oral Patol Oral Cir Bucal 2005; 10: 282-288.
16. Wojnarowska F, Eady RA, Burge SM. Bullous eruptions. 1817-1897. In: Rook A, Wilkinson DS, Ebling FJG (Eds). Textbook of Dermatology, 6th edn. Oxford; Blackwell Science, 1998.
17. Robinson JC, Nur FL, Frieden I. Oral pemphigus vulgaris. A review of the literature and report on the management of 12 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997; 84: 349-355.
18. Brenner S, Tur E, Shapiro J et al. Pemphigus vulgaris: environmental factors. Occupational, behavioral, medical, and qualitative food frequency questionnaire. Int J Dermatol 2001; 40: 562-569.
19. Markitziu A, Pisanty S. Pemphigus vulgaris after infection by Epstein-Barr virus. Int J Dermatol 1993; 32: 917-918.
20. Goon ATJ, Tay YK, Tan SH. Pemphigus vulgaris following varicella infection. Clin Exp Dermatol 2001; 26: 661-663.
21. Edelson RL. Pemphigus-decoding the cellular language of cutaneous autoimmunity. New Engl J Med 2000; 343: 60-61.
22. Grunwald MH, Katz I, Friedman B. Association of pemphigus vulgaris and herpes simplex virus infection. Int J Dermatol 1986; 25: 392-393.
23. Yair D, Shenhav M, Botchan A, Reuben Peyser M, Lessing JB. Pregnancy associated with pemphigus. Brit J Obstet Gynaecol 1995; 102: 667-669.
24. Wohl Y, Brenner S. Pemphigus in Israel- an epidemiological analysis of cases in search of risk factors. Isr Med Assoc J 2003; 5: 410-412.
25. Tsankov N, Vassileva S, Kamarashev J, Kazandjieva J, Kuzeva V. Epidemiology of pemphigus in Sofia, Bulgaria: a 16-year retrospective study (1980-1995). Int J Dermatol 2000; 39: 104-108.
26. Salmanpour R, Shahkar H, Namazi MR, Rahman-Shenas MR. Epidemiology of pemphigus in south-western Iran: A 10 year retrospective study (1991-2000). Int J Dermatol 2006; 45: 103-105.
27. Goldberg I, Ingher A, Brenner S. Pemphigus vulgaris triggered by rifampin and emotional stress. Skinmed 2004; 3: 294.
28. Ong CS, Cook N, Lee S. Drug-related pemphigus and angiotensin converting enzyme inhibitors. Australas J Dermatol 2000; 41: 242-246.
29. Woldegiorgis S, Swerlick R. Pemphigus in Southeastern United States. Southern Med J 2001; 94: 694-698.
30. Basheer AA. Bullous diseases in Malaysia: epidemiology and natural history. Int J Dermatol 1992; 31: 42-5.
31. Myskowski PL, White MH, Ahkami R. Fungal disease in the immunosuppressed host. Dermatol Clin 1997; 15: 1-14.
32. Özdemir F, Erboz S, Ünal I, Alper S, Özol A, Aytimur M. Generalized Trichophyton rubrum infection in a subject with pemphigus. J Europ Acad Derm Vener 2000; 14: 229-230.
33. Švecová D, Chmurová N, Pallová A. Immunosuppressed patients with pemphigus vulgaris are of high risk of severe dermatophyte infection. 2 case reports. Case Rep Clin Pract Rev 2007; 8: 349-352.